Spots Global Cancer Trial Database for disitamab vedotin injection
Every month we try and update this database with for disitamab vedotin injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer | NCT06227156 | Castration-resi... | Disitamab Vedot... | 18 Years - | RemeGen Co., Ltd. | |
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer | NCT06178159 | Breast Cancer | Disitamab Vedot... Pertuzumab Inje... Toripalimab | 18 Years - | RemeGen Co., Ltd. | |
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy | NCT06221748 | Gastric Cancer Gastroesophagea... | Disitamab Vedot... Cadonilimab Inj... Paclitaxel Inje... | 18 Years - 75 Years | RemeGen Co., Ltd. |